CASH AND CASH EQUIVALENTS |
CASH AND CASH EQUIVALENTS As of December 31, 2022, and March 31, 2022, cash and cash equivalents consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
March 31, 2022 |
|
|
|
(Recasted) |
Short term deposits in National Bank (Kazakhstan) |
$ |
350,203 |
|
|
$ |
42,517 |
|
Securities purchased under reverse repurchase agreements |
129,955 |
|
|
19,947 |
|
Short term deposits in commercial banks |
98,846 |
|
|
70,155 |
|
Short term deposits on brokerage accounts |
43,507 |
|
|
71,061 |
|
Petty cash in bank vault and on hand |
20,552 |
|
|
18,607 |
|
Short term deposits in stock exchanges |
19,293 |
|
|
2,828 |
|
Overnight deposits |
1,667 |
|
|
— |
|
Cash in transit |
63 |
|
|
35 |
|
Short term deposits in the Central Depository (Kazakhstan) |
9 |
|
|
314 |
|
Total cash and cash equivalents |
$ |
664,095
|
|
|
$ |
225,464
|
|
As of December 31, 2022, and March 31, 2022, cash and cash equivalents were not insured. As of December 31, 2022, and March 31, 2022, the cash and cash equivalents balance included short-term collateralized securities received under reverse repurchase agreements on the terms presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2022 |
|
Interest rates and remaining contractual maturity of the agreements |
|
Average interest rate
|
|
Up to 30 days |
|
30-90 days |
|
Total |
Securities purchased under reverse repurchase agreements
|
|
|
|
|
|
|
|
Corporate debt |
16.09 |
% |
|
$ |
70,363 |
|
|
$ |
— |
|
|
$ |
70,363 |
|
Non-US sovereign debt |
13.15 |
% |
|
40,678 |
|
|
— |
|
|
40,678 |
|
US sovereign debt |
2.74 |
% |
|
18,596 |
|
|
— |
|
|
18,596 |
|
Corporate equity |
18.57 |
% |
|
318 |
|
|
— |
|
|
318 |
|
Total securities sold under repurchase agreements |
|
|
$ |
129,955
|
|
|
$ |
—
|
|
|
$ |
129,955
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 (Recasted) |
|
Interest rates and remaining contractual maturity of the agreements |
|
Average interest rate
|
|
Up to 30 days |
|
30-90 days |
|
Total |
Securities purchased under reverse repurchase agreements |
|
|
|
|
|
|
|
US sovereign debt |
16.38 |
% |
|
$ |
9,952 |
|
|
$ |
— |
|
|
$ |
9,952 |
|
Non-US sovereign debt |
12.51 |
% |
|
9,786 |
|
|
— |
|
|
9,786 |
|
Corporate equity |
16.90 |
% |
|
152 |
|
|
— |
|
|
152 |
|
Corporate debt |
11.88 |
% |
|
57 |
|
|
— |
|
|
57 |
|
Total securities sold under repurchase agreements |
|
|
$ |
19,947
|
|
|
$ |
—
|
|
|
$ |
19,947
|
|
The securities received by the Company as collateral under reverse repurchase agreements are liquid trading securities with market quotes and significant trading volume. The fair value of collateral received by the Company under reverse repurchase agreements as of December 31, 2022, and March 31, 2022, was $137,377 and $19,911, respectively.
|